Edwards Lifesciences Corp. (NYSE:EW): Piper Jaffray raised its price target for Edwards Lifesciences citing the reduction of risk from the positive national coverage decision, positive FDA panel meeting on high-risk patients, and the Supreme Court decision on the Affordable Care Act. The firm reiterates an Overweight rating on the stock.
Peabody Energy Corp. (NYSE:BTU): Citigroup said it sees trading and investment opportunities in U.S. coal miners following the significant year-to-date sell-off in the sector. Citi recommends companies with international growth opportunities such as Peabody Energy (NYSE:BTU) and Walter Energy (NYSE:WLT), and highlights Alpha Natural (NYSE:ANR) and Arch Coal (NYSE:ACI) as plays on a domestic thermal recovery.
AeroVironment, Inc. (NASDAQ:AVAV): After meeting with management, Benchmark Co. believes AeroVironment has good visibility for its FY13 guidance and says the stock’s valuation remains compelling at current levels. The firm also thinks the company can become an attractive acquisition target in the coming years. Benchmark Co. has a Buy rating on AeroVironment with a $38 price target.
Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT): Leerink says last night, the US PTO posted a notice of allowance for Purdue/Transcept’s ‘177 patent for Intermezzo, which generally signals a greater likelihood of final issuance. The firm views the development as a positive for Transcept Pharmaceuticals and keeps an Outperform rating on the stock.
Triangle Petroleum Corporation (AMEX:TPLM): Canaccord said Triangle’s Bakken operations have had encouraging results and that its pressure pumping unit is underappreciated. Shares are Buy rated.
Don’t Miss: Why is Microsoft ABANDONING This Product?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.